209 related articles for article (PubMed ID: 36180367)
1. Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA).
Chevli PA; Islam T; Pokharel Y; Rodriguez F; Virani SS; Blaha MJ; Bertoni AG; Budoff M; Otvos JD; Shapiro MD
J Clin Lipidol; 2022; 16(6):870-877. PubMed ID: 36180367
[TBL] [Abstract][Full Text] [Related]
2. High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis.
Zhang W; Speiser JL; Ye F; Tsai MY; Cainzos-Achirica M; Nasir K; Herrington DM; Shapiro MD
J Am Coll Cardiol; 2021 Sep; 78(11):1083-1094. PubMed ID: 34503676
[TBL] [Abstract][Full Text] [Related]
3. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of Lipoprotein-Associated Phospholipase A
Tibuakuu M; Kianoush S; DeFilippis AP; McEvoy JW; Zhao D; Guallar E; Ballantyne CM; Hoogeveen RC; Blaha MJ; Michos ED
Am J Cardiol; 2018 May; 121(9):1056-1064. PubMed ID: 29525060
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of high sensitivity C-reactive protein in a multi-ethnic population after >10 years of follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA).
Cainzos-Achirica M; Miedema MD; McEvoy JW; Cushman M; Dardari Z; Greenland P; Nasir K; Budoff MJ; Al-Mallah MH; Yeboah J; Blumenthal RS; Comin-Colet J; Blaha MJ
Int J Cardiol; 2018 Aug; 264():158-164. PubMed ID: 29776564
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study.
Hussain A; Sun C; Selvin E; Nambi V; Coresh J; Jia X; Ballantyne CM; Hoogeveen RC
Eur J Prev Cardiol; 2022 Mar; 29(2):e53-e64. PubMed ID: 33580780
[TBL] [Abstract][Full Text] [Related]
7. Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH Registry.
Martin SS; Faridi KF; Joshi PH; Blaha MJ; Kulkarni KR; Khokhar AA; Maddox TM; Havranek EP; Toth PP; Tang F; Spertus JA; Jones SR
Clin Cardiol; 2015 Nov; 38(11):660-7. PubMed ID: 26459191
[TBL] [Abstract][Full Text] [Related]
8. Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality.
Doi T; Langsted A; Nordestgaard BG
Atherosclerosis; 2023 Aug; 379():117141. PubMed ID: 37217436
[TBL] [Abstract][Full Text] [Related]
9. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Remnant Lipoprotein Cholesterol and Oxidized Low density Lipoprotein Associated with Low-grade Inflammation in Coronary Heart Disease Subjects of Young South Indian Population.
Jaishankar T; Shivasekar M; Vinodhini VM
J Assoc Physicians India; 2022 Jun; 70(6):11-12. PubMed ID: 35702834
[TBL] [Abstract][Full Text] [Related]
11. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.
Quispe R; Martin SS; Michos ED; Lamba I; Blumenthal RS; Saeed A; Lima J; Puri R; Nomura S; Tsai M; Wilkins J; Ballantyne CM; Nicholls S; Jones SR; Elshazly MB
Eur Heart J; 2021 Nov; 42(42):4324-4332. PubMed ID: 34293083
[TBL] [Abstract][Full Text] [Related]
12. Combined Effect of Small Dense Low-Density Lipoprotein Cholesterol (sdLDL-C) and Remnant-Like Particle Cholesterol (RLP-C) on Low-Grade Inflammation.
Izumida T; Nakamura Y; Hino Y; Ishikawa S
J Atheroscler Thromb; 2020 Apr; 27(4):319-330. PubMed ID: 31462603
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts.
Nanna MG; Navar AM; Wojdyla D; Peterson ED
J Am Geriatr Soc; 2019 Dec; 67(12):2560-2567. PubMed ID: 31411740
[TBL] [Abstract][Full Text] [Related]
14. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
[TBL] [Abstract][Full Text] [Related]
15. Comparison of interleukin-6 and high-sensitivity C-reactive protein for cardiovascular risk assessment: Findings from the MESA study.
Ferreira JP; Vasques-Nóvoa F; Neves JS; Zannad F; Leite-Moreira A
Atherosclerosis; 2024 Mar; 390():117461. PubMed ID: 38306764
[TBL] [Abstract][Full Text] [Related]
16. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment.
Yeboah J; Young R; McClelland RL; Delaney JC; Polonsky TS; Dawood FZ; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
J Am Coll Cardiol; 2016 Jan; 67(2):139-147. PubMed ID: 26791059
[TBL] [Abstract][Full Text] [Related]
17. Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL.
Fujihara Y; Nakamura T; Horikoshi T; Obata JE; Fujioka D; Watanabe Y; Watanabe K; Kugiyama K
Circ J; 2019 May; 83(6):1302-1308. PubMed ID: 30996151
[TBL] [Abstract][Full Text] [Related]
18. Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease.
Xiao Z; Lin Z; Xu L; Xu W; Huang H; Wang Y; Cao S; Xie Z; Liao W; Liao Y; Bin J; Feng W; Chen Y
Eur J Prev Cardiol; 2023 Nov; 30(17):1924-1934. PubMed ID: 37708385
[TBL] [Abstract][Full Text] [Related]
19. Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events.
Wu F; Juonala M; Jacobs DR; Daniels SR; Kähönen M; Woo JG; Sinaiko AR; Viikari JSA; Bazzano LA; Burns TL; Steinberger J; Urbina EM; Venn AJ; Raitakari OT; Dwyer T; Magnussen CG
Circulation; 2024 Jan; 149(3):217-226. PubMed ID: 38014550
[TBL] [Abstract][Full Text] [Related]
20. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
Diabetologia; 2023 Dec; 66(12):2238-2249. PubMed ID: 37776347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
